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When an individual is exposed to Mycobacterium tuberculosis (Mtb) three outcomes
are possible: bacterial clearance, active disease, or latent infection. It is generally
believed that most individuals exposed to Mtb become latently infected and carry the
mycobacteria for life. How Mtb is maintained during this latent infection remains largely
unknown. During an Mtb infection in mice, there is a phase of rapid increase in bacterial
numbers in the murine lungs within the first 3 weeks, and then bacterial numbers
either stabilize or increase slowly over the period of many months. It has been debated
whether the relatively constant numbers of bacteria in the chronic infection result from
latent (dormant, quiescent), non-replicating bacteria, or whether the observed Mtb cell
numbers are due to balance between rapid replication and death. A recent study of
mice, infected with a Mtb strain carrying an unstable plasmid, showed that during the
chronic phase, Mtb was replicating at significant rates. Using experimental data from
this study and mathematical modeling we investigated the limits of the rates of bacterial
replication, death, and quiescence during Mtb infection of mice. First, we found that to
explain the data the rates of bacterial replication and death could not be constant and
had to decrease with time since infection unless there were large changes in plasmid
segregation probability over time. While a decrease in the rate of Mtb replication with
time since infection was expected due to depletion of host’s resources, a decrease in
the Mtb death rate was counterintuitive since Mtb-specific immune response, appearing
in the lungs 3–4 weeks after infection, should increase removal of bacteria. Interestingly,
we found no significant correlation between estimated rates of Mtb replication and
death suggesting the decline in these rates was driven by independent mechanisms.
Second, we found that the data could not be explained by assuming that bacteria do
not die, suggesting that some removal of bacteria from lungs of these mice had to
occur even though the total bacterial counts in these mice always increased over time.
Third and finally, we showed that to explain the data the majority of bacterial cells (at
least ∼60%) must be replicating in the chronic phase of infection further challenging
widespread belief of nonreplicating Mtb in latency. Our predictions were robust to
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some changes in the structure of the model, for example, when the loss of
plasmid-bearing cells was mainly due to high fitness cost of the plasmid. Further
studies should determine if more mechanistic models for Mtb dynamics are also able
to accurately explain these data.
Keywords: Mycobacterium tuberculosis, mathematical model, chronic infection, plasmid loss, pathogenesis,
replication rate, death rate, mouse
1. INTRODUCTION
Tuberculosis (TB) is one of the oldest known human infectious
diseases and together with HIV/AIDS is now the greatest global
killer due to a single infectious agent (WHO, 2013, 2014).
Roughly 9 million new active tuberculosis cases are diagnosed
and over 1 million die from the disease each year (Bourzac,
2014; Murray et al., 2014; WHO, 2014; Glaziou et al., 2015).
Throughout human history, TB is estimated to have killed over
1 billion individuals (Paulson, 2013).
TB is caused by Mycobacterium tuberculosis (Mtb), an
actinomycete closely related to saprophytic bacteria. Natural
infection with Mtb occurs by inhalation, followed by ingestion
of bacteria by lung-resident alveolar macrophages that provide
the major initial replication niche for the pathogen (Repasy
et al., 2013). After phagocytosis by the macrophage, the
mycobacterium is retained within a phagocytic vacuole
(phagosome) by inhibition of phagosome-lysosome fusion
(Takayama et al., 2005).
Following exposure of humans to Mtb, three outcomes are
possible (Flynn and Chan, 2001; Monack et al., 2004; Gideon
and Flynn, 2011). First, bacteria may get rapidly engulfed by
macrophages or other cells in the lung and cleared. Second, initial
innate response may fail clearing the bacteria, and the bacterial
population will grow in size leading to active disease. Third,
initially replicating bacteria may be contained by the adaptive
immunity within structures called granulomas leading to latent
infection in which bacteria persist for long periods of time,
often the lifespan of the host (Flynn and Chan, 2001; Monack
et al., 2004; Gideon and Flynn, 2011). The relative proportion
of exposed individuals resulting in particular type of infection is
generally poorly understood, but some studies cite 5%/95% ratio
for active disease vs. latent infection, with few if any individuals
clearing Mtb completely (Kamat et al., 1966; Comstock et al.,
1974; O’Garra et al., 2013; Getahun et al., 2015). A nearly 20
year old extrapolation suggests that roughly one-third of the
human population is latently infected (Dye et al., 1999), although
this estimate needs to be re-evaluated given novel methods of
detecting latent infection and overall decline in TB incidence
(Getahun et al., 2015). Furthermore, it is generally believed that
latently infected individuals have ∼5–10% life-time chance of
developing active disease (Monack et al., 2004; Barry et al.,
2009; Horsburgh et al., 2010; Shea et al., 2014; Zheng et al.,
2014). The most recent estimates for TB reactivation have been
questioned, however, due to biases in selecting patients and some
assumptions involved in calculating reactivation rates (Houben
et al., 2014; Sanderson et al., 2014). Irrespectively of the exact
rate of reactivation, the majority of reactivation cases appear to
be contracted in the developing world and are strongly associated
with overcrowding and malnutrition (Lawn and Zumla, 2011).
While some individuals exposed to Mtb do become latently
infected, it remains poorly understood how bacteria are
maintained during the latent infection in humans. The location
and physiological state of the bacilli in latent infection
remain largely unknown and has hindered efforts to combat
reactivation of latent tuberculosis. Generally there are two
possibilities of how Mtb is able to persist during latent infection.
First, the bacteria may enter a non-replicative, dormant stage
hidden from the host immunity. Second, the bacteria may
be maintained by the constant replication and removal by
immunity. A combination of these two mechanisms where
a fraction of bacteria actively replicates and another fraction
is quiescent, is also possible. Distinguishing between these
alternative mechanisms is potentially difficult in humans but can
be addressed by using Mtb infection of laboratory animals.
Mtb is capable of infecting multiple mammalian species, and
symptoms and overall pathogenesis caused by Mtb vary from
species to species (O’Toole, 2010; Franzblau et al., 2012; Dartois
and Barry, 2013; Myllymäki et al., 2015). Due to low cost, ease
of genetic manipulation, and availability of reagents mice are
the most commonly used experimental model of Mtb infection
and immune response dynamics, despite major differences in
pathogenesis of TB in humans and mice (Dartois and Barry,
2013; Myllymäki et al., 2015). In mice infected intranasally
with a low dose of Mtb, the total number of bacteria in the
lungs increases exponentially for 3 weeks and then plateaus for
several months (Gill et al., 2009; Ernst, 2012) (but a decline
in Mtb counts after the peak was observed in some studies
Gallegos et al., 2008; Zhang et al., 2012). As in the case of
human infection, how Mtb is maintained in the chronic phase of
infection of mice is also poorly understood. Because this state of
apparent latency (also called dormancy or quiescence) may make
bacteria resistant to host immunity or antibiotics, understanding
mechanisms of Mtb maintenance during chronic infection is of
high importance. One commonly accepted view is that bacilli,
residing in granulomas, are responsible for disease reactivation
and that these bacilli become dormant in response to high-stress
conditions (Barry et al., 2009). Although the exact location of
viable dormant mycobacteria during persistent infections has yet
to be elucidated, bacteria are often found inside macrophages
within granulomas, which are formed in response to persistent
intracellular pathogens (Monack et al., 2004).
In contrast with the “latency/dormancy” hypothesis, several
other studies suggested that there may be substantial continuous
bacterial replication during the chronic stages of infection
(Boshoff and Barry, 2005; Gill et al., 2009). Past studies of mouse
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lung histopathology during chronic infection have indicated
deterioration of tissue health and progressive inflammation,
despite stable bacterial counts (Rhoades et al., 1997; Boshoff and
Barry, 2005). These results are inconsistent with non-replicating
bacteria, and show evidence that substantial replication and
killing of mycobacteria may still be taking place during
chronic stages of infection, even though bacterial population
counts remain stable, which can be referred to as “dynamic
equilibrium.”
An important breakthrough in understanding chronic Mtb
persistence (in mice) was achieved recently (Gill et al., 2009).
The authors used a Mtb strain carrying a plasmid pBP10 with
kanamycin resistance. The plasmid was stably maintained in
culture in the presence of kanamycin but was lost in the absence
of antibiotic at a constant (per cell division) rate (Bachrach et al.,
2000; Gill et al., 2009). Because the frequency of plasmid-bearing
cells in the population declines only when there is cell division,
the dynamics of bacteria can be used to estimate the rate of
Mtb replication in vivo (Gill et al., 2009). By combining the
use of a simple mathematical model and experimental data on
the dynamics of plasmid-bearing and plasmid-free mycobacteria
the authors for the first time provided quantitative estimates of
how quickly Mtb replicated and died during infection of mice.
The analysis revealed that in comparison to acute infection (first
2 weeks) bacterial replication rate was reduced only four fold
during the chronic infection providing strong support for the
“dynamic equilibrium” hypothesis.
Here we use mathematical modeling to reanalyze these
previously published experimental data and to investigate
robustness of previously found estimates of the rates of Mtb
replication and death during infection in mice. Our analysis
suggests that estimates of Mtb replication and death rates
strongly depend on the model structure and value of other
parameters, although some conclusions such as decline in
the rate of Mtb replication and death over the course of
infection appear to be relatively robust assuming a constancy of
plasmid loss probability. Our work also highlights the need for
additional independentmeasurements of the plasmid segregation
probability and plasmid fitness cost in vivo to better quantify
Mtb dynamics, e.g., to estimate the fraction of quiescent,
nonreplicating bacteria.
2. MATERIALS AND METHODS
2.1. Data
In our analysis we used experimental data from previously
published study (Gill et al., 2009), in which the details of
experimental procedures are described in detail. In short,
C57BL/6mice were aerosol infected with a low dose ofMtb strain
H37Rv carrying a plasmid pBP10. The plasmid is thought to be a
low copy number plasmid although the exact average number of
plasmid copies per Mtb cell has not been published (Bachrach
et al., 2000). Mtb cell numbers in the lungs were measured at
5 different time points post infection (day 1, 13, 26, 69, 111)
by plating lung homogenates from n = 5 mice per time point
and counting the number of colony forming units (CFUs). The
total CFUs per lung and the percent of plasmid-bearing cells
were recorded (Figure 1). Following previous work (Gill et al.,
2009), we define time intervals during which parameters of the
models (see below) are assumed to be constant; these intervals
are days 1–13, 13–26, 26–69, and 69–111. We also provide these
experimental data in Supplemental Information (Data Sheet 1).
2.2. Main Mathematical Models
2.2.1. Extended Model
In order to quantify the rate of Mtb replication, r(t), and
death, δ(t), in vivo, Gill et al. (2009) proposed a mathematical
model that described the change in the number of plasmid-
carrying and plasmid-free bacteria with respect to time. Plasmid-
free and plasmid-bearing strains were assumed to have the
same growth and death rates, which were taken to be constant
within time intervals but could change between time intervals
(Gill et al., 2009, Figure 2). We extended the model by also
allowing the segregation probability s = s(t) to change with
time but be constant for a specific time interval. Under these
assumptions, the extended model for Mtb replication in mice
becomes:
FIGURE 1 | Kinetics of Mtb replication in mice (Gill et al., 2009). Mice were infected intranasally with a low dose of Mtb strain H37Rv carrying a plasmid pBP10;
the plasmid was lost by bacteria at cell division. Data are for the total number of bacteria and number of plasmid-bearing bacteria in the murine lungs (A) or the
percent of plasmid-bearing cells in the population (B). Markers denote measurements for individual mice (n = 5 per time point) and lines are connecting geometric
means of bacterial counts. The total deviation of the log10-transformed data from the geometric mean in (A) is 3.26, and therefore according to the lack of fit test,
best fit models should have the sum of squared residuals close to this value (Bates and Watts, 1988).
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FIGURE 2 | Cartoon of the general mathematical model of Mtb
dynamics in mice. In the model, plasmid-bearing (P) and plasmid-free (F )
bacteria replicate and die at rates r and δ, respectively, and plasmid-free
bacteria are formed during a division of plasmid-carrying cell with the
probability s. We consider two versions of the general model. In our first
version (extended model) q = 0 and rates r and δ and probability s could all be
time-dependent (see Equations 1 and 2) while the original study of Gill et al.
(2009) had a constant segregation probability s. In the second version
(quiescence model) we allow formation of quiescent cells, Pq and Fq, following
cell division with a probability q > 0 (see Equations 7–10). In the quiescence
model, the rates r and δ and probability q could be time-dependent, while
probability of plasmid loss was fixed to a value determined from in vitro
experiments, s = 0.18 (Gill et al., 2009).
dP(t)
dt
= [r(t)(1− s(t))− δ(t)]P(t), (1)
dF(t)
dt
= [r(t)− δ(t)]F(t)+ r(t)s(t)P(t), (2)
dN(t)
dt
= [r(t)− δ(t)]N(t), (3)
where N(t) = P(t) + F(t) is the total number of bacteria, P(t)
is the number of plasmid-carrying bacteria, F(t) is the number
of plasmid-free bacteria, and t is time in days. In the model,
the segregation probability s(t) denotes the probability that a
plasmid-free cell will be produced from a division of a plasmid-
bearing cell. Parameters for the mathematical model are defined
as follows:
(
r(t), δ(t), s(t)
)
=


(r1, δ1, s1), if 1 ≤ t < 13,
(r2, δ2, s2), if 13 ≤ t < 26,
(r3, δ3, s3), if 26 ≤ t < 69,
(r4, δ4, s4), if 69 ≤ t < 111.
(4)
Note that in the previous work the probability of plasmid
segregation was determined in vitro and was fixed to value
s = 0.18 in further analyses of in vivo data (Gill et al., 2009).
However, in general segregation probability could vary from 0 to
1 with s = 1 representing a situation when following division
of a plasmid-bearing cell one of the daughter cells is always
plasmid-free.
2.2.2. Linear Regressions
In the extended model (Equations 1–3), for every time period in
the data we have three parameters, ri, δi, and si (see Equation 4).
Given that for a given time period we only have measurements
of two Mtb subpopulations (plasmid-bearing and plasmid-free
cells), we can only estimate two slopes from experimental data
(Gill et al., 2009, Figure 1A). Given two slopes, the following
relationships between parameters exist
siri = SlopeNi − SlopePi, (5)
ri − δi = SlopeNi, (6)
where SlopeNi and SlopePi are slopes estimated by fitting linear
regression lines through plots of the ith intervals of ln[N(t)] and
ln[P(t)] vs. t, respectively (Gill et al., 2009). Because only two
slopes are estimated from the data while the extended model
has three parameters, we consider 3 alternative sub-models
for Mtb dynamics: (i) model with a constant, time interval-
independent segregation probability s, (ii) model with a constant,
time interval-independent replication rate r, and (iii) model
with a constant, time interval-independent death rate δ. With
one of the parameters of the model being set to a fixed value,
other parameters can be estimated from the data using linear
regressions for log-transformed total number of bacteria (N(t))
and the number of plasmid-bearing cells (P(t)).
2.2.3. Quiescence Model
It is possible that not all bacteria in mice are replicating. To
investigate how large the fraction of non-replicating bacteria
could be, we propose the following mathematical model. In the
model, following cell division a fraction of bacteria go into a
non-replicating quiescent state at a time-dependent rate q(t).
Assuming that the segregation probability is constant in this
model, s(t) = s, and that both q(t) and s are small [so then
product sq(t) can be neglected] the dynamics of plasmid-bearing
and plasmid-free cells is given by equations:
dP(t)
dt
= [r(t)(1− s− q(t))− δ(t)]P(t), (7)
dF(t)
dt
= sr(t)P(t)+ [r(t)(1− q(t))− δ(t)]F(t), (8)
dPq(t)
dt
= q(t)r(t)P(t), (9)
dFq(t)
dt
= q(t)r(t)F(t), (10)
where Pq(t) and Fq(t) are the total number of dormant
(or quiescent) plasmid-carrying and plasmid-free bacteria,
respectively. We consider two situations when dormant bacteria
are able to revert their state and grow on plates in vitro (then the
total number of bacteria N(t) = P(t)+ F(t)+ Pq(t)+ Fq(t)), and
when dormant bacteria are unable to replicate in vitro and in vivo
(N(t) = P(t)+ F(t)). Similar calculations apply to populations of
plasmid-bearing and plasmid-free cells. In this model, the rates
of bacterial replication and death and quiescence probability are
defined as a piecewise constant function similarly to Equation (4).
As another alternative model we also consider a model in which
quiescent cells are removed at the same rate as replicating cells;
results of the analysis of this model are given in Supplemental
Information (Table S1).
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2.3. Alternative Mathematical Models
2.3.1. Model with Fitness Cost for the Plasmid
Previous analysis assumed that the reason for accumulation
of plasmid-free cells in the population was due to a high
segregational probability s = 0.18 (Gill et al., 2009). This
in part stemmed from the observation of a linear decline
of the log-transformed fraction of plasmid-bearing cells in
the population over time in in vitro experiments (Gill et al.,
2009). However, because of noise in the data it is possible
that both segregational probability and fitness cost of carrying
the plasmid may contribute to the overall increase in the
fraction of plasmid-free cells (Ganusov and Brilkov, 2002).
To investigate this issue further we modified the extended
mathematical model (Equations 1–3) by fixing s(t) = s and
introducing fitness cost c in the bacterial replication rate (Gill
et al., 2009)
dP(t)
dt
= [r(t)(1− s)(1− c)− δ(t)]P(t), (11)
dF(t)
dt
= [r(t)− δ(t)]F(t)+ s(1− c)r(t)P(t). (12)
Using simple algebra it can be shown that change in the
total number of bacterial cells (N(t)) and the frequency of
plasmid-bearing cells in the population (f (t)) are given by
equations
dN(t)
dt
= r(t)N(t)(1− cf (t)), (13)
df (t)
dt
= −r(t)f (t)[s(1− c)+ c(1− f (t))]. (14)
In this model the change in the total number of bacteria
and the frequency of plasmid-bearing bacteria now depend
on the frequency of plasmid-bearing cells in the population
f (t). Importantly, for f (t) ≈ 1, the rate of decline of the
log-transformed frequency of plasmid-bearing cells is now
determined by both the segregational probability s and fitness
cost c, and as previously, is directly proportional to the rate of
Mtb replication r(t). By using previously published data from in
vitro experiments on the decline in the frequency of plasmid-
bearing cells we found that the data could be explained assuming
a range of values for s and c; at the extreme case of s = 0.04 and
c = 0.16 the model was still adequate at describing the data (Gill
et al., 2009) as compared to a model with no fitness cost (s = 0.18
and c = 0) based on AIC (results not shown).
2.3.2. Logistic Growth Model
Our main mathematical models did not make any assumptions
of specific mechanisms regulating changes in the rate of Mtb
replication and death.We therefore investigated if a model which
assumes logistic growth forMtb was able to accurately explain the
experimental data. In this model bacteria replicate at a density-
dependent rate with a maximum replication rate r and carrying
capacity K:
dP(t)
dt
= r(1− s)
(
1−
P(t)+ F(t)
K
)
P(t)− δP(t), (15)
dF(t)
dt
= r
(
1−
P(t)+ F(t)
K
)
F(t)
+ rs
(
1−
P(t)+ F(t)
K
)
P(t)− δF(t). (16)
In total, this model has 5 parameters: r, K, δ, P(0) and F(0) when
s = 0.18.
2.4. Statistics
Some of our analyses focused on estimating replication and
death rates of Mtb using linear regressions as outlined above.
In addition, to investigate further how many parameters are
needed to accurately explain the data we also fitted a series of
mathematical models of different levels of complexity to the data
which included the number of total and plasmid-bearing bacteria
in murine lungs (Figure 1A). In these fits we log10-transformed
model predictions and the data.
The models were fitted in R (version 3.1.0) using modFit
routine in FME package by minimizing the sum of squared
residuals. Numerical solutions to the system of equations were
obtained using ODE solver lsoda (from the deSolve package) with
an absolute and relative error tolerance of 10−6. The L-BFGS-B
and Marquart algorithms were used to find parameter estimates
providing the best fit of models to data. Discrimination between
different models was done using corrected AIC (Burnham and
Anderson, 2002). The model with the minimal AIC score among
all tested models was viewed as the best fit model, but a difference
of AIC score of 1–3 between best fit and second best fit models
was generally viewed as not significant. A difference in AIC score
of greater than 3 was generally viewed as significant, so the model
with a lower AIC score was interpreted as a better fit model
(Burnham and Anderson, 2002).
To test the statistical significance of the differences between
the replication (and death) rates found for different time intervals
using linear regressions with a fixed segregation probability
s = 0.18, we used a bootstrap approach (Efron and Tibshirani,
1993). We resampled the data corresponding to individual mice
with replacement to generate 5 measurements of total and
plasmid-bearing bacteria per time point 104 times using the
RandomChoice routine in Mathematica. Values for growth and
death rates for each interval were then calculated using Equations
(5) and (6), and bootstrap samples were used to calculate the
difference between estimates of growth or death rates for two
consecutive time periods (e.g., r2 − r1). The p-values, indicating
statistical significance of the difference, were calculated as
number of bootstrapped negative differences divided by 104.
Confidence intervals for parameters of our best ODE-based
models (e.g., Equations 1 and 2) were determined by resampling
data for individual mice with replacement using 103 simulations.
3. RESULTS
In their pioneering study, Gill et al. (2009) infectedmice withMtb
strain carrying a plasmid and followed the dynamics of the total
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number of bacteria and the number of plasmid-bearing bacteria
(Figure 1). The authors developed a very simple mathematical
model, based on few assumptions, and estimated the rates of Mtb
replication and death from their experimental data. However, the
original study did not fully address the question of how robust
the obtained estimates were relative to the assumptions made in
the model. Here we extend this study by determining robustness
of parameter estimates relative to several changes in the model
assumptions (Figure 2).
Fewer Parameters Are Needed to Explain
the Data
In their original analysis, Gill et al. (2009) estimated four
replication (r) and four death (δ) rates for different time intervals
during Mtb infection of mice (see Section 2 for more detail).
While replication rate was predicted to decline during the
infection, death rate was changing non-monotonically with time
since infection and was nonsignificantly different from zero
in one time interval. To investigate whether these individual
parameters truly change during the infection we used a bootstrap
approach whereby we resampled our data with replacement to
create bootstrap replicates and estimated r and δ for four time
periods. Assuming a fixed segregation probability s = 0.18,
TABLE 1 | Bootstrap analysis suggested non-significant changes in the
rates of Mtb replication and death for several time periods.
Growth rate p-value Death rate p-value
r1, r2 < 10
−4 δ1, δ2 < 10
−4
r2, r3 0.0064 δ2, δ3 0.11
r3, r4 0.19 δ3, δ4 0.19
We resampled experimental data of Gill et al. (2009) 104 times with replacement and
generated distribution of estimates for replication (r) and death (δ) rates during four time
periods assuming a fixed segregation probability s = 0.18. The indicated p-values are
calculated from the distribution of differences between two consecutive rates.
we found that there were significant differences between the
following parameter pairs: r1 and r2, r2 and r3, and δ1 and δ2
(Table 1). Thus, we show that during chronic phase of infection
(more than 69 days post infection) there is little change in
the rate of Mtb replication and death and that the rate of
Mtb death was only changing during first 2 weeks of infection.
To corroborate these findings we fitted a series of ODE-based
mathematical models in which parameters for cell replication and
death were kept constant for different time periods (Table 2).
Model fitting revealed that indeed the best fit was provided
by the model in which three replication and two death rates
during the infection were needed (see “Constrained model 1”
in Table 2). Fits predicted that both replication and death rates
decline during the infection. Importantly, while the decline in
the Mtb replication rate during infection can be explained (e.g.,
depletion of resources), decline of death rate is harder to explain
especially because 3 weeks post infection, Mtb-specific T cell
responses arrive to the lung, and are expected to increase removal
rate of bacteria by activating lungmacrophages (Jung et al., 2005).
Varying Plasmid Segregation Probability,
Replication and Death Rates
Prior in vitro experiments showed that the plasmid pBP10 has
a constant probability loss per generation, s = 0.18 (Gill
et al., 2009). Although the in vitro segregation probability was
independent of the growth rate, it is unknown whether the
plasmid segregation probability is different between in vitro and
in vivo, and whether segregation probability changes during Mtb
infection in vivo. Some experimental data do suggest that plasmid
segregation rates may depend on growth conditions which are
likely to change during in vivo infection (Wouters et al., 1980;
Popova et al., 1992; Mosrati et al., 1993; Smith and Bidochka,
1998; Ganusov and Brilkov, 2002). For example, the number of
plasmid copies per bacterial cell plays a major role in determining
the probability of formation of a plasmid-free cell (Paulsson and
Ehrenberg, 1998, 2000), and some studies suggest changes in
TABLE 2 | Fitting the extended mathematical model to experimental data suggested that few parameters were needed to explain the data.
Full Model
(day−1) r1 r3 r3 r4 δ1 δ2 δ3 δ4 AIC SSR
0.78 0.30 0.13 0.17 0.46 0.04 0.13 0.16 −116.98 3.26
Constrained Model 1
(day−1) r1 r2 r3 δ1 δ2 AIC SSR
0.72 0.40 0.14 0.40 0.13 −124.72 3.29
Constrained Model 2
(day−1) r1 r2 δ1 δ2 AIC SSR
0.49 0.21 0.18 0.20 −114.45 4.24
Constrained Model 3
(day−1) r1 r2 δ1 AIC SSR
0.50 0.20 0.19 −116.51 4.27
Assuming s = 0.18 we numerically solved the model given in Equations (1) and (2), fitted model solutions to the data on dynamics of the total number of bacteria and the number of
plasmid-bearing bacteria (Figure 1A), and estimated model parameters (see Equation 4). Resulting parameters, the sum of squared residuals (SSR), and AIC scores for the model fits
are indicated in columns. The lowest AIC score was provided by Constrained Model 1 (“3r/2δ” model), with three replication (r1, r2, r3) and 2 death (δ1, δ2 ) rates which is similar to the
results found in Table 1. This model could accurately describe experimental data based on the lack of fit test [F(3, 40) = 0.11, p = 0.95], and was not worse than the full model with four
replication and four death rates [F-test for nested models, F(3, 40) = 0.11, p = 0.95]. Visually model fits were indistinguishable from lines shown in Figure 1A. For our minimal (“3r/2δ”)
model we have the following 95% confidence intervals obtained by bootstrapping the data with replacement 103 times: r1 = 0.72 (0.63 − 0.82)/day, r2 = 0.40 (0.33 − 0.49)/day,
r3 = 0.14 (0.12− 0.15)/day, δ1 = 0.40 (0.32− 0.49)/day, δ2 = 0.13 (0.11− 0.14)/day, P(0) = 200 (165–240), F(0) = 67 (26–107).
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plasmid copy number in different culture conditions (Jones et al.,
1980; Lin-Chao and Bremer, 1986). Because pBP10 is a low copy
number plasmid (Bachrach et al., 2000), even small changes in the
copy number are likely to lead to a large change in the probability
of plasmid loss.
Mathematically, the segregation probability of plasmids may
vary between 0 and 1. A segregation probability of 1 implies
that after a replication cycle, only one of daughter cells has
the plasmid; a value greater than 1 is therefore biologically
infeasible (unless the plasmid can be degraded intracellularly or
“expelled” by a cell). Therefore, we fixed segregation probability
s to different constant values and estimated Mtb replication
and death rate using Equations (5) and (6). This analysis
suggested that the rates of replication and death strongly
depended on the actual value of the segregation probability,
and that lower values of segregation probability naturally led to
higher values of the Mtb replication and death rates (Table 3
and Figures 3A,B). Furthermore, analysis suggested that there
was a limit on the constant segregation probability for the
parameters to be all positive; this value is s = 0.204 and it is
larger than the value found in in vitro experiments (Gill et al.,
2009).
Previous work also established that the rate of Mtb replication
should decline during the Mtb infection of mice (Gill et al.,
2009). We therefore investigated if the general model (Equations
1 and 2) in which the rate of Mtb replication is constant during
the infection can explain the data for biologically reasonable
parameters assuming that both death rate and segregation
probability change with time since infection. Our analysis
suggested that it is possible (Table 4). The analysis also revealed
that there is a limit on the constant rate of Mtb replication,
r = 0.328 per day below which the data cannot be explained
(Table 4 and Figures 3C,D). Additionally, in order for the model
with a constant replication rate to be consistent with the data,
segregation probability has to change dramatically, 5–7 fold
(e.g., for r = 1 per day, see Table 4) over the course of
infection. Independent measurements of the plasmid segregation
probability in these in vivo experiments would further allow to
determine if a constant rate of Mtb replication is consistent with
the data.
Finally, we investigated whether the data could be explained
by a model in which the rate of cell death is constant during
the infection. Because the total number of bacteria continuously
increased during the infection (Figure 1A), we first investigated
whether these data can be explained with a model in which
Mtb death rate is zero. Of note, the original analysis showed
non-significant Mtb death rate in 13–26 days post infection but
positive death rates in other periods. Interestingly, the model
with δ = 0 was not able to explain the data since it required
unrealistically high segregation probability during the chronic
infection (Table 5 and Figures 3E,F). In fact, the data could only
be only explained at the minimal constant rate of Mtb death of
δ ≈ 0.05 per day (Table 5). Therefore, our analysis suggested
that bacteria must be removed during the infection including
the chronic stage of infection. It is interesting to note that the
decline in Mtb counts in murine lungs after initial expansion of
the bacterial population observed in some (Gallegos et al., 2008;
Zhang et al., 2012) but not other (Jung et al., 2005; Gallegos
et al., 2011) studies also indicated removal of bacteria. Similarly
to the analysis with a constant replication rate, a model with a
constant death rate can be consistent with the data but it would
require 3–5 fold decline in segregation probability over the course
of infection. This decline is smaller than that for a constant
replication rate, and yet may be higher than what is expected
from in vitro experiments. Similarly to the suggestion given
above, independent measurements of segregation probability in
vivo would allow to make a stronger conclusion as to whether
there are changes in the rate of Mtb death with time since
infection.
Model Predicts That Most Cells are
Replicating in the Chronic Stage of
Infection
It is generally viewed that a majority of people infected with
Mtb will eventually develop a latent infection (Flynn and Chan,
TABLE 3 | Estimates of Mtb replication and death rates strongly depended on the value for the plasmid segregation probability s.
s Day 1–13 Day 13–26 Day 26–69 Day 69–111
r1 (day
−1) δ1 (day
−1) r2 (day
−1) δ2 (day
−1) r3 (day
−1) δ3 (day
−1) r4 (day
−1) δ4 (day
−1)
0.05 2.842 2.514 1.084 0.819 0.477 0.470 0.603 0.592
0.08 1.776 1.448 0.678 0.412 0.298 0.290 0.377 0.366
0.18 0.789 0.461 0.301 0.036 0.133 0.125 0.167 0.157
0.204 0.697 0.368 0.266 0.000 0.117 0.109 0.148 0.137
0.28 0.508 0.179 0.194 −0.072 0.085 0.078 0.108 0.097
0.38 0.374 0.046 0.143 −0.123 0.063 0.055 0.079 0.069
0.48 0.296 −0.032 0.113 −0.152 0.050 0.042 0.063 0.052
Smax 0.433 0.204 3.108 2.920
We fixed the value of s = si and calculated replication ri and death δi rates using linear regressions in Equations (5) and (6). Gray boxes denote parameters outside physiologically
feasible ranges. The value of segregation probability s yielding δi = 0 was the upper bound for s in that interval (smax). The smallest of these maximum values, smax = 0.204, was the
upper bound for the segregation probability when it was constant throughout infection.
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FIGURE 3 | Dramatic dependence of the estimated replication r and death δ rates and segregation probability s on the assumptions in the model. We
made assumptions on the value of a constant segregation probability s (A,B), constant replication rate r (C,D), and constant death rate δ (E,F) and estimated
remaining parameters using linear regressions (Equations 5 and 6) from experimental data (Figure 1A). Gray areas of each plot denote values that are physiologically
impossible. Plotted values were also listed in Tables 3–5.
2001; Monack et al., 2004; Gideon and Flynn, 2011). Bacteria in
the latent infection are thought to be resistant to drug therapy,
and one possibility is that these bacteria are non-replicating in
vivo but can be “awakened” with appropriate conditions (Zhang,
2004). Our extended model (Equations 1–3), which is based
on the previous work (Gill et al., 2009), however, does not
include the possibility of latency. Therefore, we changed the
model to allow for formation of dormant/quiescent bacterial
cells during the infection which are not able to replicate or die
but can be recovered (or not) when plated in vitro (Figure 2).
The model included an additional time-dependent parameter
q(t) describing the probability of formation of a quiescent cell
following a division of a replicating cell (see Equations 7–10).
Because only two parameters can be estimated in a given time
interval from measurements of the total number of bacteria and
number of plasmid-bearing bacteria, it was impossible to estimate
parameters r, δ, s, and q from these data alone. Therefore, in our
analysis we fixed segregation constant to s = 0.18 as measured
previously in in vitro experiments (Gill et al., 2009), fixed
quiescence probability to several different values, and estimated
remaining parameters r and δ. As an additional output of the
model, we calculated the fraction of bacteria in the quiescent
state out of total bacteria (%Q = (Pq(111) + Fq(111))/N(111))
at 111 days post infection. Percent quiescent bacteria serves
as indication of how many bacteria may be quiescent in the
chronic phase while there is a decay in the fraction of plasmid-
bearing cells in the population, implying bacterial replication
(Figure 1B).
Interestingly, a range of quiescence probabilities allowed
for reasonably good fits of the data with relatively low
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TABLE 4 | Replication rate of Mtb replication was unlikely to be constant during Mtb infection of mice.
r Day 1–13 Day 13–26 Day 26–69 Day 69–111
s1 δ1 (day
−1) s2 δ2 (day
−1) s3 δ3 (day
−1) s4 δ4 (day
−1)
0.05 2.841 −0.278 1.083 −0.215 0.477 0.042 0.603 0.039
0.25 0.569 −0.078 0.217 −0.015 0.095 0.242 0.121 0.240
0.328 0.433 0.000 0.165 0.063 0.073 0.320 0.092 0.318
0.5 0.284 0.172 0.108 0.235 0.048 0.492 0.060 0.490
1 0.142 0.672 0.054 0.735 0.024 0.992 0.030 0.990
5 0.028 4.672 0.011 4.735 0.005 4.992 0.006 4.990
10 0.014 9.672 0.005 9.735 0.002 9.992 0.003 9.990
We fixed the value of replication rate r = ri and calculated segregation probability si and death rate δi using linear regressions with Equations (5) and (6). Parameters combinations
highlighted by gray boxes were outside physiologically feasible ranges. The minimal constant rate of Mtb replication was 0.328 day−1. For a constant replication rate, the segregation
probability must have declined 5–7 fold during infection for the model to be consistent with the data.
TABLE 5 | Data could not be explained assuming immortal bacteria.
δ Day 1–13 Day 13–26 Day 26–69 Day 69–111
s1 r1 (day
−1) s2 r2 (day
−1) s3 r3 (day
−1) s4 r4 (day
−1)
0 0.433 0.328 0.204 0.265 3.108 0.008 2.920 0.010
0.05 0.376 0.378 0.172 0.315 0.141 0.108 0.499 0.060
0.25 0.246 0.578 0.105 0.515 0.093 0.258 0.116 0.260
0.5 0.172 0.828 0.071 0.765 0.047 0.508 0.059 0.510
1 0.107 1.328 0.043 1.265 0.024 1.008 0.030 1.010
5 0.027 5.328 0.010 5.265 0.005 5.008 0.006 5.010
10 0.014 10.328 0.005 10.265 0.002 10.008 0.003 10.010
We fixed the value of the death rate δ = δi and calculated segregation probability si and replication rate δi using linear regressions with Equations (5) and (6) and experimental data
(Figure 1A). Parameters combinations highlighted by gray boxes were are outside physiologically feasible ranges. The minimal constant rate of Mtb death was δ ≈ 0.05 day−1. For a
constant death rate, the segregation probability must have declined 3–5 fold during infection for the model to be consistent with the data.
AIC scores with the values of q ≤ 0.05 resulting in
fits of identical quality (Figure 4 and Table 6). As expected
higher probabilities of quiescence resulted in higher rates of
replication and death (Table 6). Surprisingly, independently
of the time when generation of quiescent cells started, the
model predicted that a large fraction of bacteria at the end
of the experiment (day 111) could be in non-replicating,
quiescent state. In fact, ∼40% could be in non-replicative
state, while other bacteria replicated and died at biologically
reasonable rates in chronic infection and the model fits are
also acceptable from a statistical perspective (Figure 4). Thus,
our analysis suggests that a large fraction of quiescent, non-
replicative bacteria is not inconsistent with the data of Gill
et al. (2009). If quiescent bacteria cannot be recovered by
plating in vitro even larger percents of quiescent bacteria
would be consistent with the data (Table 6). If all bacteria can
be plated in vitro our results also suggest that at least 60%
of bacteria must be in the state of active replication during
the chronic phase of infection at the end of the experiment
(day 111). This conclusion further challenges the widespread
belief of limited Mtb replication during the chronic phase of
infection.
Alternative Models
The original study of Gill et al. (2009) and our analysis so far
assumed that the main reason for the loss of plasmid-bearing
cells in the Mtb population was a high probability of plasmid loss
at cell division (so-called segregational instability of plasmids).
However, a lower replication rate of plasmid-bearing bacterial
cells has been shown to contribute to the accumulation of
plasmid-free cells in some conditions (Zünd and Lebek, 1980;
Bentley et al., 1990; Ganusov and Brilkov, 2002). Reanalysis of
the data on the dynamics of fraction of plasmid-bearingMtb cells
in vitro (Gill et al., 2009) with a model that assumes both fitness
cost to carrying a plasmid (c > 0) and segregational instability
(s > 0) suggested that a moderate segregation probability (s ≈
0.04) and substantial fitness cost (c ≈ 0.16) are consistent
with experimental data (results not shown). Therefore we fitted
a mathematical model (Equations 11 and 12) to experimental
data on the dynamics of Mtb in murine lungs (Figure 1A) and
estimated Mtb replication and death rates for four time periods
with s = 0.04 and c = 0.16. Because in this model the decline in
the frequency of plasmid-bearing cells occurs due to cell division,
model fitting suggested a decline in the rates of Mtb replication
and death with time since infection, and further analysis showed
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FIGURE 4 | Quiescence model accurately predicted the dynamics of
total number of bacteria (A), number of plasmid-bearing bacteria (B),
and the percent of plasmid-bearing cells in the population (C) for a
range of quiescence probabilities. We fitted the mathematical model given
in Equations (7–10) to experimental data (Figure 1A) for a fixed value of
segregation probability s = 0.18 and different fixed values of the quiescence
probability q and estimated rates of Mtb replication r and death δ for four
different time periods for our minimal 3r/2δ model (see Equation 4 and
Table 2). Estimated model parameters are shown in Table 6 for “Quiescent”
model. Markers show experimental data and lines are the model predictions.
Model fits for several different values of the quiescence rate are shown and
values in square brackets are the percent of bacteria at day 111 which are in
the quiescent state. Fits were of a similar quality for models in which bacteria
become quiescent only in the chronic phase of infection [q(t) = 0 if t < 26 and
q(t) = q, otherwise], when quiescent bacteria are not counted during in vitro
plating, or when all different values are allowed for replication and death rates
for the four time intervals (see Table 6 and results not shown).
that three replication and two death rates are needed to accurately
explain the data [results not shown and F-test for nested models,
F(3, 40) = 0.06, p = 0.98]. While qualitatively the results
were independent of the exact mechanism of plasmid loss in the
population, the model with a high fitness cost of the plasmid
led to higher estimates of Mtb replication and death rates in
early infection. Specifically, we found estimates r1 = 1.2/day and
δ1 = 0.79/day which are much higher than those in the model
in which plasmid loss is driven by high segregation probability
(e.g.,Table 2). Because estimates of theMtb replication and death
rates in the chronic phase were similar in two models (results not
show), this analysis suggests that the reduction inMtb replication
rate over the course of 111 days in mice may be even more
substantial than previous analysis suggested (Gill et al., 2009).
Because in our constrained (“3r/2δ”) model we observed
substantial changes in the rate of Mtb replication and smaller
changes in the rate of Mtb death we investigated if a more
mechanistic mathematical model, based on logistic growth, was
able to describe experimental data. Therefore, we formulated a
model in which replication of bacteria is described logistically
(see Equations 15 and 16), plasmid segregation probability is
constant (s = 0.18), and bacteria are removed at a constant
rate δ. Surprisingly, this model was able to accurately describe
the change in the total number and number of plasmid-bearing
bacteria over the course of infection [results not shown and
SSR = 3.55, F(5,40) = 0.70 and p = 0.63 for lack of fit
test]. The AIC score was similar for the logistic model and
our minimal 3r/2δ model suggesting that a model in which
bacteria died at a constant rate during the infection might be
also consistent with the data. However, a closer inspection of the
fit of the logistic model to data suggested that the model was
not able to accurately predict a slow rise in the Mtb counts in
the lung in the chronic infection (see Figure 1A) and decline
in percent of plasmid-bearing cells during the first 3 weeks of
infection (results not shown). The latter observation suggests
that the type of experimental data used for fitting models may
influence the model selection process. Indeed, additional analysis
suggested that our extended model assuming three replication
and one death rates could well describe experimental data on
the dynamics of total number of bacteria and total number of
plasmid-bearing bacteria judged by the lack of fit test or F-test for
nested models (results not shown). Yet, similarly to the logistic
model, the 3r/1δ model could not accurately predict the decline
in the percent of plasmid-bearing cells in the population. Thus,
future studies utilizing Gill et al. (2009) data should focus on
describing the dynamics of the total number of bacteria and
the percent of plasmid-bearing cells in the population using, for
example, general likelihood or weighted least squares methods
(Ganusov et al., 2010).
4. DISCUSSION
While Mtb is thought to cause a persistent infection in many
exposed individuals, the state of bacteria during the latent
infection is not fully understood. Although there are many
differences in the disease caused by Mtb in humans and mice,
mice remain one of the main animal models to study Mtb
pathogenesis. Recent work by utilizing a novel Mtb strain and
a simple mathematical model suggested that during a chronic
phase of Mtb infection of mice, bacteria replicate at substantial
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TABLE 6 | Analysis predicted a high fraction of quiescent bacteria in the chronic phase of infection.
q r1 r2 r3 δ1 δ2 AIC SSR %Q
Quiescent 0 0.73 0.40 0.14 0.40 0.13 −124.72 3.29 0
0.01 0.72 0.42 0.15 0.39 0.14 −124.35 3.31 8.06
0.025 0.72 0.45 0.17 0.38 0.16 −123.50 3.37 24.73
0.05 0.75 0.48 0.19 0.41 0.18 −121.22 3.52 46.77
0.1 0.83 0.51 0.20 0.45 0.18 −117.28 3.82 73.35
Quiescent Late 0.01 0.72 0.41 0.15 0.39 0.14 −124.51 3.31 8.66
0.025 0.72 0.42 0.16 0.38 0.15 −124.0 3.34 21.83
0.05 0.73 0.44 0.18 0.41 0.17 −122.72 3.42 42.67
0.1 0.78 0.46 0.20 0.45 0.19 −119.77 3.63 72.69
Quiescent bacteria not counted 0.05 0.72 0.42 0.14 0.36 0.12 −124.64 3.29 31.55
0.1 0.71 0.43 0.13 0.32 0.11 −124.54 3.20 47.89
0.2 0.69 0.47 0.13 0.23 0.10 −124.27 3.32 64.59
We fitted the quiescence model (Equations 7–10) to experimental data (Figure 1A) with s = 0.18 and different values of q (indicated in the table) and estimated Mtb replication (r, day−1)
and death (δ, day−1) rates for different time periods (see Equation 4) assuming that there are 3 replication and 2 death rates (see Table 2). In different fits we assumed that quiescent
cells were formed during the whole infection [“Quiescent,” q(t) = q], quiescent cells were formed only in chronic phase of infection [“Quiescent Late,” q(t) = 0 if t < 26 and q(t) = q,
otherwise], quiescent cells were formed during the whole infection but could not be counted during standard plating procedure [“Quiescent bacteria not counted,” q(t) = q].
rates (Gill et al., 2009). Here we extend this pioneering study to
determine whether previous conclusions are robust to changes in
the model assumptions.
The first assumption we challenged was that the probability
of plasmid segregation is constant during the infection. It
is known that environmental conditions can influence the
segregational stability of plasmids, as well as contribute
to plasmid deamplification (Smith and Bidochka, 1998).
The metabolic stress of maintaining plasmids in unfavorable
conditions can be alleviated through changes in probability
of plasmid loss during division (Smith and Bidochka, 1998).
Studies conducted on E. coli transformed with recombinant
plasmids and kept in continuous culture have shown that the
probability of plasmid loss is not constant and varies between
different growth rates (Wouters et al., 1980; Popova et al., 1992;
Mosrati et al., 1993; Smith and Bidochka, 1998; Ganusov and
Brilkov, 2002). In particular, Mosrati et al. (1993) showed that
the probability of plasmid loss in this particular case was not
constant, and was positively correlated with the rate of growth
of plasmid-bearing bacteria. Allowing the probability of plasmid
segregation to change over the course of Mtb infection led to
several interesting results. First, our analysis suggested that while
in our data the total number of bacteria always increased over
the course of infection, the data could not be explained assuming
immortal bacteria. Second, allowing segregation probability to
vary influenced the actual estimates of the Mtb replication
and death rates. Third, relatively large changes in segregation
probability were needed to explain experimental data with
constant replication or death rates, suggesting that previously
found decline in both rates over the course of infection is likely a
robust result (unless the segregation probability declines several
fold with time since infection). Fourth and finally, our analysis
puts limits on the constant rates of Mtb replication (rmin = 0.328
day−1), death (δmin ≈ 0.05 day
−1), and segregation probability
(smax = 0.204) for the model to be consistent with the data.
The second assumption was that all bacteria during the
infection were capable of replicating. There is clear evidence
that over the course of Mtb infection of mice, there are
changes in Mtb metabolism which could potentially result in
dormancy or non-replicative state (Barry et al., 2009; Boon
and Dick, 2012). In particular, Schnappinger et al. (2003)
measured transcriptional responses of Mtb upon phagocytosis
by macrophages. Transcription profile showed expression of
genes which correspond to adaptations to a nitrosative, oxidative,
and hypoxic environment. Genes responsible for cell envelope
repair were also actively expressed. This shows evidence of a
harsh environment within the phagosome; adaptations to these
conditions have been reported to be associated with a dormancy-
related phenotype in Mtb. Genes responsible for fatty-acid
metabolism were also upregulated in this study, indicating that
the primary carbon source within the phagosome are fatty acids.
In vitro studies have also shown that when Mtb is grown in the
presence of long-chain fatty acids as the primary carbon source,
it enters a state genetically comparable to dormancy (Rodríguez
et al., 2014).
Extending the previous model to allow for formation
of quiescent, non-replicating bacteria led to two interesting
predictions. First, a range of quiescence probabilities was
consistent with experimental data but at higher values the
model fits predicted a large increase in replication and death
rates in the chronic infection for several versions of the model
(Table 6). Such an increase in the replication rate is unlikely to
be true biologically (Barry et al., 2009). Second, for biologically
reasonable parameters about 25–40% of bacteria recovered at
the end of experiments (day 111 post infection) could be in
dormant, non-replicative stage. Thus, these experimental data are
compatible with the notion that many bacteria during chronic
infection are non-replicating even though there is a continuous
loss of plasmid-bearing cells in the population (Figure 1B). Our
analysis thus put a limit on the fraction of quiescent bacteria
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which are still expected to be the minority of the population. Our
results also suggested that during chronic phase of infection the
majority of mycobacterial cells in the lung must be replicating.
In our analysis we assumed that these quiescent bacteria
were unable to die. This was due to the idea that Mtb death
occurs during bacterial replication. We also tested models which
assumed that quiescent bacteria would die at the same rate as
non-quiescent bacteria and it was found that a model with even
higher rates of quiescence is able to explain the data, although
that model predicted a smaller fraction of quiescent bacteria at
the end of experiments (Table S1 in Supplemental Information).
Additional experiments will be needed to determine the size
of the fraction of non-replicating bacteria during the chronic
infection. One set of such experiments could involve treatment
of mice, infected with this Mtb strain, with antibiotics. For
example, isoniazid is currently believed to kill rapidly dividing
mycobacteria while pyrazinamide or rifampin also act on slowly
growing or nonreplicating bacteria (Mitchison, 2000; Horsburgh
et al., 2015). TreatingMtb-infectedmice with different antibiotics
and recording the kinetics of loss of plasmid-bearing cells would
allow for an independent test of the fraction of rapidly replicating
bacteria in the chronic phase of infection (given that our current
understanding of how these drugs work in vivo in mice is correct,
Horsburgh et al., 2015).
Our analysis still supports a previous conclusion that both
Mtb replication and death rate are likely to decline during the
infection (Gill et al., 2009) unless there are large changes in
the probability of plasmid loss. Statistical tests suggested that
for a constant probability of plasmid segregation (s = 0.18),
replication rate declines during first 2 months post infection
while death rate only declines in the first 3 weeks. Decline in
the replication rate over the course of infection may be expected
as bacteria exhaust host’s resources (e.g., macrophages) or due
to formation of granulomas which may limit access of bacteria
to nutrients such as oxygen. However, the decline in the death
rate over the course of infection was unexpected since 3–4
weeks post-infected, Mtb-specific T cells arrive to the lung (Jung
et al., 2005) and are expected to enhance macrophage-mediated
killing of bacteria. If there was a strong correlation between
the rate of bacterial replication and cell death, for example if
cells are most susceptible to die during cell division, we would
expect to see a decline in the rate of cell death (because the
rate of cell replication declines). Indeed, several previous studies
found that some bacteria are very susceptible to antibiotics
when they rapidly divide providing indirect support for this
hypothesis (Tuomanen et al., 1986; Evans et al., 1990; Gilbert
et al., 1990) (but see Raffetseder et al., 2014). However, we
found no significant correlation between Mtb replication and
death rates for 4 time periods, in part due to unexpectedly
low death death rate in 13–26 days post infection (Figure 5).
This non-significant correlation was further confirmed by the
inability of the ODE-based model (Equations 1 and 2) assuming
δi = αri with α = const to accurately explain experimental
data [results not shown and F(2, 40) = 8.46 and p < 0.001
in lack of fit test]. Thus, further studies are needed to explain
why the Mtb death rate declined during the first 3 weeks post
infection.
FIGURE 5 | Absence of significant correlation between the rate of Mtb
replication and rate of Mtb death during the infection. We estimated the
rates of Mtb replication (r) and death (δ) for four time periods using linear
regressions (Equations 5 and 6) and letting s = 0.18. These estimates are
identical to those given in Gill et al. (2009). Statistical analysis of the correlation
was performed using Spearman rank correlation with p-value indicated on the
graph. Error bars denote confidence intervals for parameter estimates
obtained by bootstrapping data from individual animals 104 times. The
regression line was drawn for illustrative purposes.
Although our extensions of the mathematical model of Gill
et al. (2009) were relatively simple, they still ignored several
additional mechanisms which can also impact estimates of the
Mtb replication and death rates. For example, the pBP10 plasmid
may bear a fitness cost and thus could reduce the rate of
replication of plasmid-bearing cells. Gill et al. (2009) showed that
presence of a small fitness cost will lead to higher estimates for the
replication and death rates of bacteria. We extended their result
by fitting an alternative model, in which plasmid loss probability
is small and fitness cost is large, to experimental data. The general
result that both replication and death rates decline during the
infection remained robust but numerically indeed, high fitness
cost led to higher estimates of the Mtb replication and death rates
during the first 2 weeks of infection. It should be noted, however,
that given strikingly exponential increase in the total number of
bacterial cells and decline in percent of plasmid-bearing cells in
in vitro experiments (Gill et al., 2009), it is unlikely that carriage
of plasmid bears high fitness cost. Previous analyses illustrated
that if fitness cost of carrying the plasmid is large, population size
and percent of plasmid-bearing cells would change according to
a bi-exponential function, and not single exponential (Ganusov
and Brilkov, 2002, and results not shown).
Another assumption of our and previous analyses was that
plasmids are lost from the cell only following cell division. While
it is not very likely, plasmid could be also lost from a cell
due to degradation process, activated in the chronic infection.
Additional data are needed to confirm stability of the plasmid in
harsh, in vivo-like conditions.
All of our analysis involved the data on the dynamics of
the total number and the number of plasmid-bearing Mtb
cells in the lung (Figure 1A). A closer inspection of the data
revealed one outlier mouse which had significantly lower Mtb
counts in the lung at day 13 post infection. While we have no
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biological reasons to exclude this specific data point from our
main analyses, we nevertheless repeated most of our analyses
excluding that outlier mouse from the data. Although excluding
the outlier did affect estimates of several parameters, none of
the conclusions were affected (results not shown). Because we
also performed simulations to evaluate confidence intervals for
parameter estimates, we believe that major conclusions reached
in our paper were robust to that specific peculiarity in the
data.
A series of detailed mathematical models of the within-
host dynamics of Mtb has been developed in the last 10 years
(Gammack et al., 2004; Marino and Kirschner, 2004; Kirschner
and Marino, 2005; Fallahi-Sichani et al., 2011; Marino et al.,
2011; Pienaar et al., 2015). Such models took into account the
complexity of the Mtb replication in macrophages and Mtb-
specific immune response in the lymph nodes and lung; however,
very limited in vivo experimental data were used to calibrate
such models. Most of parameters of such models (e.g., Marino
and Kirschner, 2004; Fallahi-Sichani et al., 2011) were estimated
from indirect experimental data on Mtb growth in vitro or in
vitro and in vivo immune responses to model antigens or other
pathogens. Many other parameters were guessed to constrain
model dynamics. We do not know if one version of such models
would be able to explain Gill et al. (2009) data but given the
complexity of such detailed models and the number of free
parameters, it is very likely. However, model overfitting of the
data should not be viewed as model confirmation (Oreskes et al.,
1994). As Enrico Fermi, a Nobel prize laureate, once said: “with
four parameters I can fit an elephant, and with five, I can make
him wiggle his trunk” (Mayer et al., 2010; Ditlev et al., 2013).
There is a need for relative simple mathematical models of
within-host Mtb dynamics whose complexity is driven not by
the biological complexity of the phenomenon (which can be
explored ad infinitum), but by the inability of simpler models
to accurately describe in vivo data. This is in line with “strong
inference” in science (Platt, 1964). In particular, it remains to be
determined if simple, so-called standardmodels for the dynamics
of intracellular pathogens (Perelson, 2002), are able to explain
experimental data of Gill et al. (2009). Given that logistic model
is able to only partially explain these data it is possible that more
complex mechanistic models are indeed needed to accurately
describe Gill et al. (2009) data (e.g., Figure 1B).
Since our analysis was done for the data coming from Mtb
infection of mice, relevance of our findings to Mtb infection
of humans remains unclear. Clearly, many aspects of TB
pathogenesis are different between mice and humans, and more
recent studies suggested that Mtb dynamics in monkeys may be
more representative of what happens in humans (Scanga and
Flynn, 2014; Flynn et al., 2015). Such conjecture can be debated
given our limited understanding of human TB. Detailed data on
Mtb dynamics in monkeys, similar in quality and amount to the
work of Gill et al. (2009) are not yet publicly available for analysis,
so application of our modeling approach to Mtb infection of
monkeys will be only possible when similar data are generated
and made available. For example, infection of monkeys with
this Mtb strain may provide information on the birth and death
processes regulating the number of bacteria found in individual
granulomas (Lin et al., 2014). At this point our analysis provided
quantitative estimates on how Mtb may behave in mice and
future work in monkeys and humans will be needed to evaluate
relevance of these findings to human TB.
One of the main conclusions of our work is that even for
a quite extensive set of experimental data and relatively simple
mathematical models, estimates of the model parameters are
not always robust to the changes in model assumptions and
some of our conclusions challenge previous results. Furthermore,
alternative models (e.g., a model the dormant/quiescent state)
can also explain the data with similar quality. Our analysis thus
suggests that to constrain model predictions and to discriminate
between alternative models additional measurements are needed.
As we mentioned earlier, several different mechanistic models for
the Mtb replication in mice and humans have been constructed
(e.g., see review Kirschner and Marino, 2005); however, which
mechanisms of such complex models are truly needed to explain
major qualitative and quantitative features of Mtb infection in
mice remains undefined. Experimental data such as those of Gill
et al. (2009) as well as other studies utilizing plasmid pBP10
could be a valuable source for testing and rejecting different
mechanistic models of Mtb replication in mice and possibly in
monkeys.
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